Saturday, October 7, 2017: 12:30 PM Background. ECMO recipients who develop bloodstream infections (BSI) meeting CLABSI criteria are publically-reported in inter-facility comparisons and contribute to potential penalties from CMS. We aimed to determine the incidence of BSI, specifically CLABSI, following receipt of ECMO at one of the largest ECMO centers in the US.
Background.
With the rising use of midline catheters (MC), validation of their safety is essential. The objective of our study was to evaluate the incidence of bloodstream infections (BSI) and other complications related to the use of MC and central venous catheter (CVC).
Methods. A retrospective cohort study was performed from May-December 2016 at Detroit Medical Center, Detroit, MI. Adult patients were eligible for inclusion if they had either MC or CVC during hospitalization. Outcomes assessed were line-related BSI per the National Healthcare Service Network (NHSN) criteria, mechanical complications (nonfunctional line due to disruption in patency or dislodging), hospital length of stay, mortality and readmission within 90 days of discharge. Statistical analysis was performed using SAS software.
Results. A total of 312 patients with MC and 215 patients with CVC were analyzed. The mean age of cohort was 57 ± 17.4 years and 52% were females. Higher catheter-related BSIs (CRBSI) were seen in patients with CVC (7/215) compared with MC (1/312); (3.3 vs. 0.3%; P = 0.009). Among the CRBSI, alternative source of infection was identified in both MC (1/1) and CVC group (2/7). Two of the 7 CVC-related BSI were reported to NHSN. More mechanical complications were seen in MC (3.5%) compared with CVC group (0.4%) (P = 0.03). Patients with CVC had higher crude mortality (14% vs 6%, P = 0.002), readmission rate (51% vs 38%, P = 0.004) and line-related readmissions (5.7% vs 0.8%, P = 0.05) compared with MC group. Multivariate analysis showed female gender (OR 0.55, 95% CI 0.38-0.81), burns (OR 0.21, 95% CI 0.06-0.74), myocardial infarction (OR 0.17, 95% CI 0.08-0.36) and stay in the intensive care unit (OR 0.60, 95% CI 0.41-0.88) had higher likelihood to receive MC while CVC was more likely to be inserted in patients with chronic kidney disease (OR 2.86, 95% CI 1.84-4.44).
Conclusion. Patients with chronic kidney disease are more likely to get CVC and hence particular attention should be paid to prevent BSI through appropriate catheter care. MC are more common in patients with burns, myocardial infarction and in the intensive care unit. Larger studies are needed to understand if MC or CVC are independent predictors for BSI.
Disclosures. All authors: No reported disclosures. Background. Extracorporeal membrane oxygenation (ECMO) has been used in various clinical settings, such as acute respiratory distress syndrome, cardiogenic shock and refractory septic shock. One of the associated risks is acquisition of infections during bypass because of the multiple cannulation sites. The purpose of this study was to evaluate the predictors of healthcare associated infections (HAI) and mortality in adult patients on ECMO.
Predictors of Infections and Mortality in Adult Patients
Methods. This was a retrospective descriptive study at a 1550 bed Universityaffiliated tertiary medical center in Miami, Florida. We looked at patients over 18 years old on ECMO for > 48 hours between January 1-August 31, 2016. The presence of an infection before ECMO placement or acquired during ECMO support were noted. Only culture-proven infections were included. The primary outcome was to identify risk factors associated with HAI or mortality.
Results. 40 patients undergoing ECMO during the study period were identified. 25 patients met the inclusion criteria and were included in the analysis. During a total of 364 ECMO days, 12 patients out of 25 had microbiologically proven infection (48 %). There were 7 ventilator associated pneumonias (41%), 5 bacteremias (29%), 2 pleural empyemas (12%), 2 Clostridium difficile colitis (12%) and 1 mediastinitis (6%). Candida species were the predominant blood isolates (60%). The rate of infection per 1,000 ECMO days was 46.7.
The overall in-hospital mortality was 64%. There was no impact of infection on mortality, length of ICU,or hospital stay. ECMO use for < 7 days was associated with overall less episodes of infection vs ECMO use for > 7 days. (P-value 0.0136, OR 0.089, CI: 0.01-0.6). Charlson-comorbidity score of 5 or more was associated with higher episodes of bacteremia (P = 0.0023, OR = 16, CI = 1.38-185.41).
Conclusion. Infections did not have an impact on mortality. Patients on ECMO for less than 8 days had less episodes of infections. Patients with Charlson-comorbidity index of 5 or more were associated with higher episodes of bacteremia. Further prospective cohort studies are necessary to address causality and to determine infection and mortality predictors that can be modified for patients undergoing ECMO.
Disclosures. All authors: No reported disclosures. ; 1 22% of reported CLABSIs for the medical (MICU) and cardiothoracic surgical ICUs (CTICU). 10 (77%) CLABSI patients had femoral sites of ECMO cannulation and/or CVC insertion and 12 (92%) were receiving broad-spectrum antibiotics at the time of CLABSI. Patients with CLABSI and secondary BSI predominantly had infections due to gram-negative rods (Fig 1) . The organism recovered from the BC was susceptible to the antibiotics received in 14 (48%) of patients with positive BC. Conclusion. The rate of CLABSI was more than 3 times higher in our cohort of ECMO recipients than nationally reported rates for academic MICUs and CTICUs. Research is needed to understand the preventability of these infections, as traditional prevention measures such as avoidance of the femoral site and prophylactic ABX may not be applicable or effective in this high-risk population. Furthermore, NHSN should update its CLABSI definition and/or risk adjustment to account for hospitals with high ECMO utilization. Background. Community-onset (CO) methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection (BSI) prevalence is a significant predictor of hospital-onset rates, and >80% of MRSA BSIs are CO-MRSA. We describe geographic distribution and characteristics of hospitals with higher CO MRSA BSI rates.
To Be a CLABSI or Not to Be a CLABSI-That Is
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Methods. Data on CO MRSA BSIs (positive blood cultures collected in outpatient locations or ≤3 days after admission) were obtained from general hospitals reporting MRSA BSI events facility-wide for all of in 2015 to the National Healthcare Safety Network (NHSN). Hospital characteristics were obtained from NHSN and the American Hospital Association 2015 Annual Survey. Using hospital admissions as a measure of hospital volume, we calculated unadjusted pooled CO MRSA rates (events/1000 admissions) by census division and performed a negative binomial regression for adjusted rate ratios (aRRs) and 95% confidence intervals (CI) for facility characteristics associated with higher facility-level CO MRSA BSI rates.
Results. Of the 3,401 general hospitals that reported for 12 months, complete data on hospital-characteristics were available from 2,766 (85%). These hospitals reported 69,546 CO MRSA BSI events in 2015. The number of unadjusted CO MRSA BSI events/1000 admissions varied across census divisions with the highest in the Mountain Division (3.71) and the lowest in the West North Central Division (1.57). Census division, size >500 beds (aRR: 1.24, 95% CI 1.07-1.44), location in a micropolitan (containing at least one urban cluster >10,000 but <50,000 people) vs metropolitan area (aRR: 1.30, 95% CI 1.17-1.44), lower volume of surgical operations (aRR: 0.99 per 1000 operations, 95% CI 0.99-0.99), and public hospital status (aRR: 1.29, 95% CI 1.15-1.43) were all associated with higher CO MRSA BSI rates. Teaching hospital status (P = 0.48) and provision of chemotherapy (P = 0.36) and transplant services (P = 0.51) were not associated with higher CO MRSA BSI rates.
Conclusion. After controlling for several hospital characteristics, significant differences in CO MRSA BSI rates persisted among census divisions. Further understanding causes of variation in CO MRSA rates, such as the role of community characteristics in determining regional differences, could provide insight into CO MRSA BSI prevention strategies.
Disclosures. -32 ). A Monte Carlo simulation with 1000 trials simulating corrections for false positive and false negative nasal MRSA tests found very similar results. The odds of a SA infection being an MRSA infection was much lower in MSSA carriers than in MRSA carriers across all subgroups of age, sex, hospital, length of stay, and year (figure).
Conclusion. SA infections in MSSA carriers are 100 times less likely to be MRSA infections than are SA infections in MRSA carriers. Patients colonized with MSSA rarely get MRSA infections. This fact can be used to support an antimicrobial stewardship policy of actively discouraging empiric coverage for MRSA infection in MSSA carriers. 
